# Liraglutide therapy in Prader-Willi syndrome.

> PubMed lists PMID 21388446 in Diabetic medicine : a journal of the British Diabetic Association as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-06 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-21388446-liraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-11-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-21388446-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21388446-liraglutide-v1.json
- Content SHA-256: `9ff8466a39497b0481f35ea23a3b335273d273939a7b84edf90d64a5bb21416d`

## Claims and source pins

### Headline

Liraglutide therapy in Prader-Willi syndrome. ([`pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0`](#source-pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0))

### Summary

PubMed lists PMID 21388446 in Diabetic medicine : a journal of the British Diabetic Association as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-06 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0`](#source-pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0))

### Paragraph 1

PubMed lists PMID 21388446 in Diabetic medicine : a journal of the British Diabetic Association as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-06 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0`](#source-pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0`](#source-pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0))

## Sources

<a id="source-pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0"></a>
- **Liraglutide therapy in Prader-Willi syndrome. · retained source version 1:2015-11-19:current:1232b8b426a0ff580b53335d34627df51c90550d0ef41cf194abe802491a2a83** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/21388446/) (`pubmed-observation-pmid-21388446-2015-11-19-1232b8b426a0`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Liraglutide therapy in Prader-Willi syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21388446-liraglutide-v1.json SHA-256: 9ff8466a39497b0481f35ea23a3b335273d273939a7b84edf90d64a5bb21416d.